Across multiple AD models, UA exhibits anti-inflammatory properties by suppressing the synthesis and release of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and reducing the activation of microglia and astrocytes, thereby alleviating AD-related symptoms [41,61,105]. This evidence concerns the gene IL1B and Alzheimer disease.